Published in Trends Genet on June 01, 1988
Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci U S A (1989) 1.85
Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci U S A (1991) 1.24
Cellular models for disease exploring and drug screening. Protein Cell (2010) 0.85
Molecular analysis of 11 galactosemia patients. Nucleic Acids Res (1991) 0.84
Rat urate oxidase produced by recombinant baculovirus expression: formation of peroxisome crystalloid core-like structures. Proc Natl Acad Sci U S A (1992) 0.79
Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res (1988) 9.94
DNA diagnostics--molecular techniques and automation. Science (1988) 8.85
Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources. Proc Natl Acad Sci U S A (1989) 8.68
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04
Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene. Proc Natl Acad Sci U S A (1984) 6.48
Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics (1992) 6.40
DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet (1991) 6.20
Automated DNA sequencing of the human HPRT locus. Genomics (1990) 5.92
Generation of cDNA probes directed by amino acid sequence: cloning of urate oxidase. Science (1988) 5.72
Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res (1989) 5.02
Identification of the gene responsible for Best macular dystrophy. Nat Genet (1998) 4.89
Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature (1993) 4.87
Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res (1996) 4.75
DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet (1992) 4.22
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Bacterial peptide chain release factors: conserved primary structure and possible frameshift regulation of release factor 2. Proc Natl Acad Sci U S A (1985) 3.94
Expression of peptide chain release factor 2 requires high-efficiency frameshift. Nature (1986) 3.60
Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature (1999) 3.57
The American Society of Human Genetics statement on cystic fibrosis screening. Am J Hum Genet (1990) 3.07
Disease diagnosis by recombinant DNA methods. Science (1987) 3.06
Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants. Nucleic Acids Res (1982) 3.00
Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. Proc Natl Acad Sci U S A (1989) 2.97
Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology (1997) 2.94
Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics (1990) 2.84
Organization of the HPRT gene and related sequences in the human genome. Somat Cell Mol Genet (1984) 2.84
Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene. Somat Cell Mol Genet (1987) 2.77
A three-allele restriction-fragment-length polymorphism at the hypoxanthine phosphoribosyltransferase locus in man. Proc Natl Acad Sci U S A (1983) 2.73
8-Azaguanine resistance in mammalian cells. I. Hypoxanthine-guanine phosphoribosyltransferase. Genetics (1972) 2.71
Cloned cDNA sequences of the hypoxanthine/guanine phosphoribosyltransferase gene from a mouse neuroblastoma cell line found to have amplified genomic sequences. Proc Natl Acad Sci U S A (1982) 2.62
A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci U S A (1996) 2.52
The HPRT locus. Cell (1979) 2.49
Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol (1992) 2.35
PCR test for cystic fibrosis deletion. Nature (1990) 2.26
Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet (1996) 2.23
Sequential translation of trinucleotide codons for the initiation and termination of protein synthesis. Science (1968) 2.20
An economic evaluation of a genetic screening program for Tay-Sachs disease. Am J Hum Genet (1978) 2.17
Evaluation of 13 short tandem repeat loci for use in personal identification applications. Am J Hum Genet (1994) 2.15
Detection of single DNA base differences by competitive oligonucleotide priming. Nucleic Acids Res (1989) 2.14
Absence of messenger RNA and gene DNA for beta-globin chains in hereditary persistence of fetal hemoglobin. Cell (1976) 2.10
Deletion and amplification of the HGPRT locus in Chinese hamster cells. Mol Cell Biol (1983) 2.10
The molecular basis of the sparse fur mouse mutation. Science (1987) 2.09
Fine structure of the human hypoxanthine phosphoribosyltransferase gene. Mol Cell Biol (1986) 2.07
Molecular evidence for new mutation at the hprt locus in Lesch-Nyhan patients. Nature (1984) 2.07
The Chinese hamster HPRT gene: restriction map, sequence analysis, and multiplex PCR deletion screen. Genomics (1991) 2.03
RNA codons and protein synthesis. 15. Dissimilar responses of mammalian and bacterial transfer RNA fractions to messenger RNA codons. J Mol Biol (1968) 2.00
Fine structure of RNA codewords recognized by bacterial, amphibian, and mammalian transfer RNA. Science (1967) 1.99
Translational frameshifting: where will it stop? Cell (1987) 1.93
Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. Biochem Biophys Res Commun (1998) 1.93
Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet (1991) 1.93
DNA chips: promising toys have become powerful tools. Trends Biochem Sci (1999) 1.93
Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology (1989) 1.88
Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A (1994) 1.88
Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci U S A (1989) 1.85
Peptide chain termination with mammalian release factor. Proc Natl Acad Sci U S A (1970) 1.82
In vitro translation of hypoxanthine/guanine phosphoribosyltransferase mRNA: characterization of a mouse neuroblastoma cell line that has elevated levels of hypoxanthine/guanine phosphoribosyltransferase protein. Proc Natl Acad Sci U S A (1981) 1.81
Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc Natl Acad Sci U S A (1995) 1.81
Mammalian peptide chain termination. II. Codon specificity and GTPase activity of release factor. Proc Natl Acad Sci U S A (1971) 1.79
Chromosome pairing in maize. Genetics (1972) 1.79
Mutations affecting the structure of hypoxanthine: guanine phosphoribosyltransferase in cultured Chinese hamster cells. Proc Natl Acad Sci U S A (1973) 1.78
Identification and localization of mutations at the Lesch-Nyhan locus by ribonuclease A cleavage. Science (1987) 1.76
Characterization of reticulocyte release factor. J Biol Chem (1977) 1.76
An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A (1998) 1.76
Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet (1995) 1.74
HPRT: gene structure, expression, and mutation. Annu Rev Genet (1985) 1.72
Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science (1988) 1.70
Peptide chain termination. V. The role of release factors in mRNA terminator codon recognition. Proc Natl Acad Sci U S A (1969) 1.68
Hydrolysis of fMet-tRNA by peptidyl transferase. Proc Natl Acad Sci U S A (1971) 1.67
Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci U S A (2000) 1.67
Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci U S A (1997) 1.66
Recent advances in peptide chain termination. Mol Microbiol (1990) 1.66
Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci U S A (1989) 1.64
Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci U S A (2000) 1.62
Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet (1995) 1.62
Mutation detection by solid phase primer extension. Hum Mutat (1996) 1.61
Identification of receptors for neuromedin U and its role in feeding. Nature (2000) 1.60
Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA (1993) 1.58
Cloning of the Escherichia coli release factor 2 gene. J Bacteriol (1984) 1.56
Methylation of the mouse hprt gene differs on the active and inactive X chromosomes. Mol Cell Biol (1986) 1.53
Expression of human and Chinese hamster hypoxanthine-guanine phosphoribosyltransferase cDNA recombinants in cultured Lesch-Nyhan and Chinese hamster fibroblasts. J Biol Chem (1983) 1.51
Molecular scanning methods of mutation detection. J Biol Chem (1990) 1.50
Scanning detection of mutations in human ornithine transcarbamoylase by chemical mismatch cleavage. Proc Natl Acad Sci U S A (1989) 1.50
Localization of a gene for Duane retraction syndrome to chromosome 2q31. Am J Hum Genet (1999) 1.46
Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer. Nature (1986) 1.44
Mutant chinese hamster cells with a thermosensitive hypoxanthine-guanine phosphoribosyltransferase. Cell (1975) 1.44
Clinical diversity of hereditary Duane's retraction syndrome. Ophthalmology (2000) 1.41
Trinucleotide repeats and genome variation. Curr Opin Genet Dev (1993) 1.39
Cloning and expression of a mammalian peptide chain release factor with sequence similarity to tryptophanyl-tRNA synthetases. Proc Natl Acad Sci U S A (1990) 1.38
Formylation of guinea pig liver methionyl-sRNA. Arch Biochem Biophys (1967) 1.38
In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther (1996) 1.37
Expression of human adenosine deaminase in murine hematopoietic cells. Mol Cell Biol (1988) 1.35
Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies. Hum Genet (1999) 1.33
Mammalian release factor; in vitro assay and purification. Methods Enzymol (1974) 1.32
Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun (1999) 1.32
Hypermutable myotonic dystrophy CTG repeats in transgenic mice. Nat Genet (1997) 1.29
Peptide chain termination: effect of protein S on ribosomal binding of release factors. Proc Natl Acad Sci U S A (1970) 1.28
Peptide chain termination. VII. The ribosomal and release factor requirements for peptide release. Proc Natl Acad Sci U S A (1970) 1.28
A molecular survey of hypoxanthine-guanine phosphoribosyltransferase deficiency in man. J Clin Invest (1986) 1.28